Literature DB >> 25391361

Case of paraneoplastic retinopathy with retinal ON-bipolar cell dysfunction and subsequent resolution of ERGs.

Shinji Ueno1, Ayami Nakanishi, Kayo Nishi, Shiro Suzuki, Hiroko Terasaki.   

Abstract

PURPOSE: To report a patient with cancer-associated retinopathy and retinal ON-bipolar cell dysfunction who had a resolution of the electroretinograms (ERGs) after a resection of an ovarian cancer and chemotherapy. CASE REPORT: A 71-year-old Japanese female patient visited us complaining of night blindness and photopsia in both eyes for 6 months. Her visual acuity was 20/20 in both eyes, and fundus examination, fluorescence angiography, and optical coherence tomography showed no abnormalities in both eyes. The rod responses of the ERGs were absent and bright-flash ERGs were electronegative. The ON responses of the focal macular ERGs and full-field long-flash ERGs were absent. These ERG findings indicate an ON-bipolar cell dysfunction. A general physical examination revealed the presence of ovarian cancer. After resection of the ovarian cancer and adjuvant chemotherapy, the ERGs of the left eye completely recovered within 2 years and those of right eye recovered subsequently. The autoantibody against transient receptor potential melastatin 1 (TRPM1) was not detected in the serum.
CONCLUSION: Our case demonstrates that retinal ON-bipolar dysfunction can be caused by ovarian cancer. Our case indicates that some autoantibodies against other than TRPM1 might cause transient dysfunction of retinal ON-bipolar cells.

Entities:  

Mesh:

Year:  2014        PMID: 25391361     DOI: 10.1007/s10633-014-9470-x

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN: 0012-4486            Impact factor:   2.379


  21 in total

1.  Nature of the cone ON-pathway dysfunction in melanoma-associated retinopathy.

Authors:  Kenneth R Alexander; Claire S Barnes; Gerald A Fishman; Ann H Milam
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-04       Impact factor: 4.799

2.  Cancer-associated retinopathy presenting as retinal vasculitis with a negative ERG suggestive of on-bipolar cell pathway dysfunction.

Authors:  Anastasios Anastasakis; Andrew D Dick; Erika M Damato; Paul G Spry; Mohamed A Majid
Journal:  Doc Ophthalmol       Date:  2011-06-15       Impact factor: 2.379

Review 3.  Clinical and immunologic characteristics of melanoma-associated retinopathy syndrome: eleven new cases and a review of 51 previously published cases.

Authors:  J L Keltner; C E Thirkill; P T Yip
Journal:  J Neuroophthalmol       Date:  2001-09       Impact factor: 3.042

4.  Localization of vanilloid receptor 1 (TRPV1/VR1)-like immunoreactivity in goldfish and zebrafish retinas: restriction to photoreceptor synaptic ribbons.

Authors:  Sarah Zimov; Stephen Yazulla
Journal:  J Neurocytol       Date:  2004-07

5.  TRPM1 is a component of the retinal ON bipolar cell transduction channel in the mGluR6 cascade.

Authors:  Chieko Koike; Takehisa Obara; Yoshitsugu Uriu; Tomohiro Numata; Rikako Sanuki; Kentarou Miyata; Toshiyuki Koyasu; Shinji Ueno; Kazuo Funabiki; Akiko Tani; Hiroshi Ueda; Mineo Kondo; Yasuo Mori; Masao Tachibana; Takahisa Furukawa
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-04       Impact factor: 11.205

6.  TRPM1 is required for the depolarizing light response in retinal ON-bipolar cells.

Authors:  Catherine W Morgans; Jianmei Zhang; Brett G Jeffrey; Steve M Nelson; Neal S Burke; Robert M Duvoisin; R Lane Brown
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-27       Impact factor: 11.205

7.  Spontaneous improvement of rod system function in a patient with melanoma-associated retinopathy.

Authors:  Linda S Kim; Kenneth R Alexander; Gerald A Fishman
Journal:  Retin Cases Brief Rep       Date:  2008

8.  Autoantibodies against retinal bipolar cells in cutaneous melanoma-associated retinopathy.

Authors:  A H Milam; J C Saari; S G Jacobson; W P Lubinski; L G Feun; K R Alexander
Journal:  Invest Ophthalmol Vis Sci       Date:  1993-01       Impact factor: 4.799

9.  Focal cone ERGs of rhodopsin Pro347Leu transgenic rabbits.

Authors:  Shinji Ueno; Toshiyuki Koyasu; Taro Kominami; Takao Sakai; Mineo Kondo; Shunsuke Yasuda; Hiroko Terasaki
Journal:  Vision Res       Date:  2013-08-21       Impact factor: 1.886

10.  Serum TRPM1 autoantibodies from melanoma associated retinopathy patients enter retinal on-bipolar cells and attenuate the electroretinogram in mice.

Authors:  Wei-Hong Xiong; Robert M Duvoisin; Grazyna Adamus; Brett G Jeffrey; Celia Gellman; Catherine W Morgans
Journal:  PLoS One       Date:  2013-08-01       Impact factor: 3.240

View more
  4 in total

1.  Thyroid malignancy presenting with visual loss: an unusual case of paraneoplastic retinopathy.

Authors:  Emily Hughes; Sarah Moran; Ian Flitcroft; Patricia Logan
Journal:  BMJ Case Rep       Date:  2016-10-19

2.  Melanoma-associated retinopathy with anti-TRPM1 autoantibodies showing concomitant Off-bipolar cell dysfunction.

Authors:  Wei-Che Hung; Hui-Chen Cheng; An-Guor Wang
Journal:  Doc Ophthalmol       Date:  2022-09-29       Impact factor: 1.854

3.  TRPM1 Autoantibodies in Melanoma Patients Without Self-Reported Visual Symptoms.

Authors:  Robert M Duvoisin; Gaoying Ren; Tammie L Haley; Matthew H Taylor; Catherine W Morgans
Journal:  Invest Ophthalmol Vis Sci       Date:  2019-05-01       Impact factor: 4.799

4.  Identification and characterization of novel TRPM1 autoantibodies from serum of patients with melanoma-associated retinopathy.

Authors:  Juliette Varin; Margaret M Reynolds; Nassima Bouzidi; Sarah Tick; Juliette Wohlschlegel; Ondine Becquart; Christelle Michiels; Olivier Dereure; Robert M Duvoisin; Catherine W Morgans; José-Alain Sahel; Quentin Samaran; Bernard Guillot; José S Pulido; Isabelle Audo; Christina Zeitz
Journal:  PLoS One       Date:  2020-04-23       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.